Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open and Phase II Clinical Study of HX008 for the Treatment in Patients With Advanced Solid Tumors

NCT03704246 is registered in ClinicalTrials.gov with Taizhou Hanzhong biomedical co. LTD as lead sponsor.

NCT NCT03704246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03704246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open and Phase II Clinical Study of HX008 for the Treatment in Patients With Advanced Solid Tumors
Lead sponsor
Taizhou Hanzhong biomedical co. LTD
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2018
Completion date
March 30, 2021
Enrollment
123 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor